‘Positive’ trial for Pfizer-BioNTech Covid-flu jab

  • 📰 vanguardngrnews
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 75%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

A Nigerian newspaper and Online version of the Vanguard, a daily publication in Nigeria covering Nigeria news, Niger delta, general national news, politics, business, energy, sports, entertainment, fashion,lifestyle human interest stories, etc

Germany’s BioNTech and US pharmaceutical giant Pfizer on Thursday announced “positive” results from initial trials of their combined mRNA vaccine against Covid-19 and influenza.

“A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months,” they said. Pfizer and BioNTech first announced in November 2022 that they were planning to use the same technology to develop a combined Covid and flu vaccine.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Atiku vs Tinubu: Supreme court raises concern over 'conflicting letters' from CSUNigeria's independent online newspaper
Source: thecableng - 🏆 2. / 80 Read more »